As of November 2026 Inhibikase Therapeutics has a market cap of A$0.29 Billion. This makes Inhibikase Therapeutics the world's 8949th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 3rd, 2026 the market cap of Inhibikase Therapeutics was reported to be: